Diabetic neuropathy pain can be effectively managed through a combination of medical treatment, lifestyle changes, and supportive therapies ...

“Myoxinol fits into a wider trend of using neuropeptides in skincare, which aim to modulate nerve signalling or muscle ...

Neuropathy occurs in the feet or hands due to nerve damage. When a patient suffers from neuropathy, they can experience so-called neuropathic pain ranging from mild to severe and described as burning, ...

The U.S. topical pain relief market alone is projected to exceed $11.5 billion by 2025, reflecting increased interest in non-systemic and non-opioid treatment alternatives.

MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric ...

Phase 2a for Diabetic Neuropathy Expected to Begin by Year-End - Preparations are underway for a Phase 2a study in diabetic neuropathy patients, with first human efficacy data expected by Q1 2026.